semaglutide 2024 Compound POLITICO Pro | Article |
Description
Alex Roig
The current recommendation is a definite discontinuation of ICI in case of grade 3 (severe) or life threatening (grade 4) immune related adverse events
We explored whether semaglutide increases the risk of appendicitis
Association between glucagon-like peptide-1 receptor agonists and thyroid cancer risk: a multinational cohort study
10.1210/endo.137.7.8770921 223
